Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 40
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07558200 | Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors | ||
| NCT04743739 | Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN | ||
| NCT07616089 | Phase I Study of FXS0683 in the Treatment of Blood Tumors | ||
| NCT07657052 | A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria | ||
| NCT06913725 | An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations | ||
| NCT05633433 | Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 | ||
| NCT05946876 | A Phase 1 Study of XH-S003 in Healthy Volunteers | ||
| NCT07750665 | FXS6837 for the Treatment for IgAN Patients（Longterm Study） | ||
| NCT05997602 | To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH | ||
| NCT06236841 | A Phase I Study of XH-S004 in Healthy Volunteers | ||
| NCT07840820 | Phase II/III Study of FXS5626 in Participants With Non-segmental Vitiligo | ||
| NCT05675748 | Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients | ||
| NCT07004075 | FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration | ||
| NCT03944499 | Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer. | ||
| NCT05755048 | FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer | ||
| NCT06936527 | XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation | ||
| NCT07345637 | Phase I Study of FXS887 in the Treatment of Solid Tumors | ||
| NCT07035652 | The Phase Ib Clinical Trial of the XH-S004 Tablet in Patients With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate Its Safety, Tolerability, Pharmacokinetic Characteristics and Pharmacodynamic Characteristics After Multiple Administrations | ||
| NCT04523571 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects | ||
| NCT06569420 | Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC | ||
| NCT07552012 | A Phase II Clinical Trial to Evaluate the Efficacy and Safety of FXS5626 in Patients With NIU | ||
| NCT04237805 | A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients | ||
| NCT05682599 | Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China | ||
| NCT03690154 | A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML | ||
| NCT07695779 | QT Interval Effects Study of Oral FXS5626 Tablets | ||
| NCT03932253 | MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b) | ||
| NCT06272747 | Study of XH-S003 in Healthy Volunteers | ||
| NCT07562581 | A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC | ||
| NCT07747090 | A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24 Weeks in Patients With PNH. | ||
| NCT05140278 | Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate | ||
| NCT07024394 | Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1 | ||
| NCT04649021 | Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population | ||
| NCT06820268 | A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies | ||
| NCT07634744 | A Phase IIa Study in Primary IgA Nephropathy Patients | ||
| NCT05913037 | FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas | ||
| NCT07728201 | Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis | ||
| NCT07502638 | FXS6837 for the Treatment of IgAN Patients | ||
| NCT04954001 | Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1 | ||
| NCT06858618 | FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms | ||
| NCT06981091 | A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis |
